[go: up one dir, main page]

TR200001147T2 - The use of macrolides for the treatment of cancer and macular degeneration - Google Patents

The use of macrolides for the treatment of cancer and macular degeneration

Info

Publication number
TR200001147T2
TR200001147T2 TR2000/01147T TR200001147T TR200001147T2 TR 200001147 T2 TR200001147 T2 TR 200001147T2 TR 2000/01147 T TR2000/01147 T TR 2000/01147T TR 200001147 T TR200001147 T TR 200001147T TR 200001147 T2 TR200001147 T2 TR 200001147T2
Authority
TR
Turkey
Prior art keywords
macular degeneration
macrolides
cancer
treatment
compound
Prior art date
Application number
TR2000/01147T
Other languages
Turkish (tr)
Inventor
Sun Or Yat
J. Plattner Jacob
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of TR200001147T2 publication Critical patent/TR200001147T2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Bir insan ya da veterinerlik hastasinda tümörler ve makular dejenerasyonun tedavi edilmesi için bir yöntem olup, bu yöntem, (I), (II), (III), (IV), ( V), (VI), (VII) formüllerini kapsayan gruptan seçilen bir bilesik ve bu formüllerin bir bilesigi ve bir farmasötik açidan kabul edilebilir tasiyici maddeyi içeren bir farmasötik bilesimin tatbik edilmesini içermektedir.A method of treating tumors and macular degeneration in a human or veterinary patient, which method is from the group consisting of formulas (I), (II), (III), (IV), (V), (VI), (VII) comprising a selected compound and a compound of these formulations and a pharmaceutical composition containing a pharmaceutically acceptable carrier.

TR2000/01147T 1997-10-31 1998-10-30 The use of macrolides for the treatment of cancer and macular degeneration TR200001147T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US96147397A 1997-10-31 1997-10-31

Publications (1)

Publication Number Publication Date
TR200001147T2 true TR200001147T2 (en) 2000-08-21

Family

ID=25504514

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/01147T TR200001147T2 (en) 1997-10-31 1998-10-30 The use of macrolides for the treatment of cancer and macular degeneration

Country Status (17)

Country Link
EP (1) EP1027060A2 (en)
JP (1) JP2001521891A (en)
KR (1) KR20010031577A (en)
CN (1) CN1278178A (en)
AR (1) AR043071A1 (en)
AU (1) AU1206799A (en)
BG (1) BG104436A (en)
BR (1) BR9813318A (en)
CA (1) CA2307850A1 (en)
HU (1) HUP0100012A3 (en)
IL (1) IL135518A0 (en)
NO (1) NO20002189L (en)
PL (1) PL340604A1 (en)
SK (1) SK6172000A3 (en)
TR (1) TR200001147T2 (en)
WO (1) WO1999022722A2 (en)
ZA (1) ZA989885B (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001079520A1 (en) 2000-04-13 2001-10-25 Biotica Technology Limited Hybrid glycosylated products and their production and use
JP2006511475A (en) 2002-09-18 2006-04-06 トラスティーズ オブ ザ ユニバーシティ オブ ペンシルベニア Method for suppressing choroidal neovascular disease
AR043050A1 (en) 2002-09-26 2005-07-13 Rib X Pharmaceuticals Inc BIFunctional HETEROCICLICAL COMPOUNDS AND METHODS TO PREPARE AND USE THE SAME
US7354574B2 (en) 2002-11-07 2008-04-08 Advanced Ocular Systems Limited Treatment of ocular disease
JP4719671B2 (en) 2003-03-28 2011-07-06 コーネル・リサーチ・ファンデーション・インコーポレイテッド Migrastatin analog composition and use thereof
US7083802B2 (en) 2003-07-31 2006-08-01 Advanced Ocular Systems Limited Treatment of ocular disease
WO2005027906A1 (en) 2003-09-18 2005-03-31 Macusight, Inc. Transscleral delivery
US7087237B2 (en) * 2003-09-19 2006-08-08 Advanced Ocular Systems Limited Ocular solutions
US7083803B2 (en) 2003-09-19 2006-08-01 Advanced Ocular Systems Limited Ocular solutions
CN1950388A (en) * 2004-02-27 2007-04-18 瑞伯-X医药品有限公司 Macrocyclic compounds and methods of making and using the same
JP5383037B2 (en) * 2004-02-27 2014-01-08 リブ−エックス ファーマシューティカルズ，インコーポレイテッド Macrocyclic compounds and methods of making and using them
JP5149001B2 (en) 2004-05-25 2013-02-20 スローン−ケッタリング・インスティテュート・フォー・キャンサー・リサーチ Migrastatin analogues in the treatment of cancer
EP1805161B1 (en) 2004-09-23 2014-05-07 Sloan-Kettering Institute For Cancer Research Isomigrastatin analogs in the treatment of cancer
GB2438544A (en) 2005-02-09 2007-11-28 Cooper Internat Corp Liquid formulations for treatment of diseases or conditions
PL1904056T3 (en) 2005-07-18 2009-09-30 Minu Llc Use of a macrolide to restore corneal sensation
EP1934237A2 (en) 2005-08-24 2008-06-25 Rib-X Pharmaceuticals, Inc. Triazole compounds and methods of making and using the same
EP1928893A2 (en) 2005-08-24 2008-06-11 Rib-X Pharmaceuticals, Inc. Triazole compounds and methods of making and using the same
CA2635797C (en) 2006-02-09 2015-03-31 Macusight, Inc. Stable formulations, and methods of their preparation and use
CN101443004B (en) 2006-03-23 2013-03-06 参天制药株式会社 Agents for diseases or conditions associated with vascular permeability
CN106317146B (en) * 2015-06-18 2019-06-21 沈阳药科大学 Bicyclic clarithromycin derivatives and their use as tumor cell proliferation inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6461090A (en) * 1989-10-30 1991-05-02 Abbott Laboratories Injectable formulation for lipophilic drugs
US5498424A (en) * 1994-11-30 1996-03-12 Klein; Ira Method of treating obesity

Also Published As

Publication number Publication date
WO1999022722A3 (en) 1999-08-05
BG104436A (en) 2000-12-29
HUP0100012A3 (en) 2003-07-28
SK6172000A3 (en) 2001-03-12
CN1278178A (en) 2000-12-27
BR9813318A (en) 2000-08-22
NO20002189L (en) 2000-06-28
PL340604A1 (en) 2001-02-12
CA2307850A1 (en) 1999-05-14
IL135518A0 (en) 2001-05-20
ZA989885B (en) 1999-05-05
EP1027060A2 (en) 2000-08-16
JP2001521891A (en) 2001-11-13
WO1999022722A2 (en) 1999-05-14
KR20010031577A (en) 2001-04-16
AR043071A1 (en) 2005-07-20
NO20002189D0 (en) 2000-04-27
HUP0100012A2 (en) 2001-05-28
AU1206799A (en) 1999-05-24

Similar Documents

Publication Publication Date Title
TR200001147T2 (en) The use of macrolides for the treatment of cancer and macular degeneration
ATE235893T1 (en) ORAL PREPARATION CONTAINING ZONULA OCCLUDENS TOXIN AND A BIOLOGICALLY ACTIVE INGREDIENT AND THEIR USE
MY129809A (en) Quinazoline derivatives
HUP0001170A3 (en) Pharmaceutical compositions containing benzimidazole-2-carbamate derivatives as active ingredients for the treatment of viral infections and cancer
DK0490077T3 (en) Antisense oligonucleotides for the treatment of cancer
AU2002236765A1 (en) Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent
GEP20033025B (en) 4,4-Biarylpiperidine Derivatives with Opioid Receptor Activity
GEP20063895B (en) Platinum derivative pharmaceutical formulations
HUP9900905A2 (en) Use of vitamin d4 derivatives for treating cancer
EE9900450A (en) Tetrahydropyrido compounds, medicament containing them and their use
DE69905384D1 (en) OSMOTIC NON-FERMENTED LAXANS FOR TREATING AND PREVENTING COLORECTAL CANCER
UA48958C2 (en) 9-0-oxime derivatives of erythromycine and pharmaceutical composition thereof
TR199801732T2 (en) New taxoids, their preparations and drug compositions.
ATE264309T1 (en) SUBSTITUTED CAPROLACTAM DERIVATIVES, PHARMACEUTICAL PREPARATIONS CONTAINING SAME AND THEIR USE FOR THE TREATMENT OF TUMORS
TW374085B (en) Novel piperidine derivatives, their preparation, pharmaceutical formulation and medical use
PL318130A1 (en) Terpenod derivatives (of sarcodictyine)as antineoplastic agents
DE69334087D1 (en) Drug composition containing TCF-II
GB9505082D0 (en) Medicament
MX9702671A (en) Metallocenic diarylethylene derivatives, methods for their preparation and pharmaceutical compositions containing same.
ATE215941T1 (en) ISOFLAVONE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME
ATE106732T1 (en) MEDICATION PREPARATION CONTAINING STIGMASTA-4-EN-3-ONE AND USE THEREOF.
MY133596A (en) Compound and method for the treatment of pain
ATE329613T1 (en) PHARMACEUTICAL PREPARATIONS CONTAINING GROWTH HORMONES INHIBITORS OR THEIR BIOLOGICALLY ACTIVE FRAGMENTS FOR THE TREATMENT OF UTERINE MYOMAS
IT1271292B (en) Pharmaceutical compositions containing melatonin and oestrogen-receptor inhibitors